Dermatological side effects include rash on the skin, itching, hives, skin redness, blisters, pale skin, peeling and swelling with or without fever
Specifications: Form: Lyophilised powder Unit Size: 50 mg Appearance: Blue to blue-green solid Storage (unreconstituted): -20 C, dark, dry Reconstitution: Sterile water for injection Stability (reconstituted): Store at 28 C, short-term Usage Notice: For research use only
Oral bioavailability has not been characterized, and the compound's heptapeptide structure (773.89 Da) makes oral activity less likely than for the smaller Dihexa (504.66 Da), though not impossible given its modified sequence
Any BPC-157 dosage figures in the literature refer to controlled experimental models
A: For the attributed members the PPS can run a report that demonstrates the number of members that have had an HgA1C in the last year
Health Secretary RFK, Jr